Although it shares the active ingredient with some weight loss drugs, Ozempic is specifically intended for diabetes control and is not approved for weight loss
B + F45 Training, virtual fitness and nutrition content support prescription treatment, empowering your unique path to better health
Weight loss with tirzepatidean incretin-based agent that activates two hormones that influence appetite, food intake, and metabolic function: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)was associated with significant improvements in various cardiometabolic risk factors, including blood pressure, lipid levels, and glycemic measures
This method facilitates in vivo knock-in across diverse tissues and organs for both dividing and non-dividing cells, such as liver, heart, muscle, and retina 5,6,7,8,9
Retatrutide's Phase 2a in MASH/MASLD (Sanyal et al., Nat Med 2024) reported approximately 86% relative reduction in liver fat content at 12 mg/week the strongest hepatic-fat data among the incretin class